ABBREVIATIONS: BW-1, bis(phenylbenzyl) 3-7-3 analogue; MDL 27695, N,N'-bis(benzyl)-substituted polyamine analogue; MSF, Malaria SYBR Green I -based fluorescence assay ABSTRACT: A series of alkylated (bis)urea and (bis)thiourea polyamine analogues were synthesized and screened for antimalarial activity against chloroquine-sensitive and -resistant strains of Plasmodium falciparum in vitro. All analogues showed growth inhibitory activity against P. falciparum at less than 3 µM, with the majority having effective IC 50 values in the 100-650 nM range. Analogues arrested parasitic growth within 24 hours of exposure due to a block in nuclear division and therefore asexual development. Moreover, this effect appears to be cytotoxic and highly selective to malaria parasites (>7000-fold lower IC 50 against P. falciparum) and is not reversible by the exogenous addition of polyamines. With this first report of potent antimalarial activity of polyamine analogues containing 3-7-3 or 3-6-3 carbon backbones and substituted terminal urea-or thiourea moieties, we propose that these compounds represent a structurally novel class of antimalarial agents.
INTRODUCTION
Malaria remains one of the most deadly parasitic diseases, with nearly 250 million new cases each year, resulting in approximately one million deaths (www.who.int). The spreading resistance of Plasmodium falciparum to existing antimalarials including chloroquine, antifolates and artemisinin has resulted in a pressing need to discover new chemotherapeutic agents against this disease.
1 One class of promising antiparasitic agents include inhibitors of polyamine biosynthesis, 2 as well as polyamine analogues, 3 with ample evidence indicating that these rapidly dividing cells have an exquisite need for the presence of polyamines for a myriad of cellular functions during cell growth and division. 4, 5 The naturally occurring polyamines putrescine (1), spermidine (2) and spermine (3) ( Figure 1 ) interact with a variety of cellular effector sites due to their highly cationic nature and specific spatial orientation of positive charge, and are therefore able to stabilize DNA, RNA and other acidic cellular constituents. 4 Polyamine analogues are structurally similar to the naturally occurring polyamines and act as either polyamine antimetabolites that deplete intracellular polyamine pools, or polyamine mimetics that displace the natural polyamines from their binding sites, without substituting for their cellular functions. 6 Particularly, terminal alkylation of polyamines and polyamine analogues results in a change of pKa of the amine groups of these molecules, resulting in non-functional polyamine characteristics. 7, 8 Moreover, these analogues may compete for polyamine uptake, and in mammalian cells in particular,
can induce polyamine catabolism. 3 The first generation of antiparasitic alkylpolyamines, typified by the N,N'-bis(benzyl)-substituted polyamine analogue MDL 27695 (4, Figure 1 ), exhibited antitrypanosomal and antiplasmodial activity in the µM range. [9] [10] [11] A bis[(2-phenyl)benzyl)]spermine analogue of 4 known as BW-1 (5, Figure 1 ) was subsequently shown to have inhibitory activity against various strains of Trypanosoma and the microsporidial, Encephalitozoon cuniculi, particularly by blocking polyamine uptake and inhibiting polyamine oxidase activity 9, 11, 12 and additionally being curative in a rodent model of infection with the microsporidial organism. 9 Derivatives of 5 include analogues of the substituted (bis)biguanide known as 2d (6, Figure 1 ) that, in addition to depleting the polyamine pool, inhibits trypanothione reductase (a spermidine-glutathione conjugate) activity in trypanosomes. 8 Compound 6 and its derivatives are highly active antiparasitic agents, with in vitro IC 50 's against T. brucei as low as 90 nM. Several urea-and thiourea-based isosteres of 6 have subsequently been shown to be effective epigenetic modulators in mammalian cells by influencing selective chromatin marks in tumor cell lines through inhibition of lysine specific demethylase 1, thereby decreasing cancerous cell growth. 13 Based on the success of terminally (bis)alkylated polyamine analogues against other parasites, several analogues of 6, as well as a new generation of (bis)urea and (bis)thiourea alkylated isosteres of 6, were synthesized and evaluated for their ability to inhibit the proliferation of malaria parasites. These compounds contain a variety of carbon backbones, and terminal urea/thiourea substituents that are symmetrically substituted aralkyl substituents, and as such present a structurally novel class of scaffolds, unrelated to any known antimalarials. This study reports the antimalarial activity against drug sensitive and resistant P. falciparum strains in vitro, their effects on the parasites' DNA replication and polyamine-specific events.
RESULTS AND DISCUSSION
Chemical syntheses of urea and thiourea polyamine analogues. To access a library of urea and thiourea analogues isosteric to 6 (7-20, Table 1 ; and 25-39, (Raney Ni) to yield the desired diamines 43. 8, 16 Compounds 43 (n = 1, 2, 4, 5) were then reacted with the 2 equivalent of appropriate alkyl-or aryl-substituted isocyanates or isothiocyanates 44 in anhydrous CH 2 Cl 2 , followed by acid removal of the N-Boc protection groups (HCl in EtOAc) 15 to afford the desired urea or thiourea products (7-20 and 25-39). The amidine analogs compounds 21-24 were prepared (Scheme 2) by reacting diamines 43 with 2 equivalent of S-naphthylmethyl thioacetimidate hydrobromide 46 (prepared by refluxing 2-bromomethylnaphthalene with thiacetamide in CHCl 3
according to literature procedure 14 ) using absolute ethanol, and the Boc protecting groups were subsequently removed with HCl in EtOAc.
In vitro activity of polyamine analogues against P. falciparum. The first diverse library of isoteric (bis)urea and (bis)thiourea alkylated polyamine analogues was tested for possible growth inhibitory affect against intraerythrocytic P. falciparum in vitro ( Table 1 ). The majority of these compounds showed in vitro inhibitory activity against both drug resistant (W2 chloroquine resistant strain, HB3
antifolate resistant strain) and sensitive P. falciparum (strain 3D7) at concentrations below 3 µM (Table   1 ). Compound 6, containing terminal (bis)diphenylpropylguanidine moieties, is active against P.
falciparum at 298 nM. Conversely, it is clear that amidine substituted analogues that lacked terminal alkyl groups were not active against the malaria parasite. Compound 21, an amidine analogue containing a 3-3-3 carbon backbone, which lacks any (bis)urea and (bis)thiourea substituents, was the least effective compound (IC 50 = 147 µM, This suggests that these analogues are minimally affected by the resistance mechanisms of e.g. chloroquine with a mechanistically distinct mode of action (Table 1) .
Analysis of the antimalarial effects of this first series of (bis)urea and (bis)thiourea alkylated polyamine analogues suggests that the most potent compounds contain either a 3-7-3 or 3-4-3 carbon backbones, with the 3-7-3 carbon backbone delivering the best activity against the parasite. Compounds with (bis)urea substituents exhibited the most potent antimalarial activity, followed by the (bis)thiourea substituted compounds. The diphenylpropyl substituents proved more effective than the diphenylethyl substituents as terminal groups of these compounds. Analysis of the amidine alkylated polyamine analogues suggests that the 3-3-3 and 3-4-3 carbon backbones are not effective against the parasite and that analogues with a 3-7-3 carbon backbone are active in the nM range, particularly when they have terminal diphenylpropyl substituents. Based on results observed with this first evaluation of the antimalarial activity of polyamine analogues, the selective design and synthesis of a second series of compounds, predicted to have a higher antimalarial capacity, was attempted. This second series of 15 compounds contained 3-6-3, 3-7-3 and 3-4-3 backbones but with a variety of terminal substituents.
Of the second series of analogues, 13 had potent antimalarial activity with IC 50 values in the range of 88-846 nM ( Table 2 ). Both of these contain 3-6-3 carbon backbones with (bis)urea substituents, similar to the structures of the most effective compounds, with the exception that they feature alkyl rather than aralkyl substituent rings. This second generation of synthesized (bis)urea and (bis)thiourea alkylated polyamine analogues suggests that the most potent compounds contain either a 3-6-3 or 3-7-3 carbon backbones, with the 3-6-3 carbon backbone delivering the best activity against the parasite. Compounds with (bis)urea substituents exhibited the most potent antimalarial activity, followed by the (bis)thiourea substituted compounds. The selection of terminal substituents of these compounds are of vital importance in enhancing their antimalarial activity, compounds with terminal phenyl rings had the best activity, followed by diphenylethyl substituents, benzyl rings and lastly diphenylmethyl substituents. Compounds with no terminal aralkyl groups were the least effective against the parasite with IC 50 values in the high µM range, thus demonstrating the importance of bulky terminal substituents for antimalarial activity.
Some terminally, symmetrically substituted polyamine analogues target DNA and exert a cytotoxic effect through DNA aggregation. 7 In most instances, the polyamine analogues (compounds 9, 13, 15, 16
and 25, 29, 30, 38, 39) elicited a significant cytotoxic response in the parasite (P<0.05), as measured by a decrease in viable cell numbers (% parasitemia, Figure 2 ). However, even through compound 20 was active against the parasite, it was not able to decrease viable cell numbers in P. falciparum over time, indicating a cytostatic action on in vitro growth. During its asexual intraerythrocytic development, P.
falciparum replicates its DNA as it develops from single-nucleated ring (1N) and trophozoite stages (1N) to multinucleated schizont (2N or >2N) stages that result in up to 32 daughter merozoites (mononucleated) being formed from a single parent parasite. 17, 18 Polyamines have been shown to be important for DNA replication and therefore implied life cycle development in Plasmodia. 19 The effects of the Treatment of P. falciparum with polyamine biosynthesis inhibitors like the substrate analogues α-difluoromethylornithine and 3-aminooxy-1-aminopropane has been shown to be reversible and therefore the inhibitory effect is alleviated with the addition of exogenous polyamines to the parasite. 20, 21 In order to investigate the influence of exogenous polyamines on P. falciparum growth inhibition observed with the current series of polyamine analogues, polyamine reversal studies were performed to determine if treated parasites could recover when supplemented with exogenous putrescine. The inhibitory effect observed with the polyamine compounds could not be reversed with exogenous polyamines for any of the most potent compounds ( Figure 4 ). The decreased cell viability observed for compound 16 was again visible over a 72 hr time period, and this was already evident after the first 24 h, during which the parasite needed to start nuclear division. Therefore, the cytotoxic action of these polyamine analogues on P. falciparum seems to be independent of changes in the polyamine pool. This may be due to the analogues' ability to block the intracellular binding sites of the natural polyamines, or to displace intracellular polyamines from their binding sites. 10 Alternatively, the mode of action of these polyamine analogues against P. falciparum may be independent of the polyamine pathway. In trypanosomes, polyamine analogues act as competitive inhibitors of enzymes not directly related to polyamine biosynthesis. 22 It remains to be seen if the polyamine analogues manifest their effect on P. falciparum through targeting epigenetic control mechanisms, as has been observed in mammalian cells. 13 The parasite seems to be exquisitely sensitive towards epigenetic regulatory mechanisms, particularly for the control of expression of variant gene families.
P. falciparum appear to be highly sensitive to the polyamine analogues described above, with the majority showing parasite IC 50 values below 500 nM. In order to ensure that this effect was not merely due to general toxicity of the compounds, in vitro cytotoxicity testing was performed in a sensitive mammalian cell line. A subset of the compounds described in this manuscript, notably 14, 15 and 16, have been evaluated as potential antitumor agents in the Calu-6 non-small cell human lung carcinoma cell line. 13 It is important to note that these compounds exert antitumor effects through re-expression of aberrantly silenced tumor suppressor genes, and as such are not inherantly cytotoxic in mammalian cells Remarkably, the most active compound (30) is ~7000-fold more selective towards the parasite.
Comparatively, compounds 14, 15 and 16 were not the most effective against P. falciparum and inhibited cell growth in Calu-6 cells at µM concentrations (Table 3) , but even these compounds showed more than ~10-fold selectivity against the malaria parasite. 13 The results presented here indicate that the compounds do not show general cytotoxicity in mammalian cells, and that P. falciparum seems to show selective sensitivity to these polyamine analogues. These results are encouraging in implicating this series of polyamine analogues as highly selective antimalarial agents. Moreover, the ability of polyamine analogues to cure in vivo infections of malaria in the murine model of P. berghei should provide clues as to the ultimate antimalarial potential of this structurally distinct class of compounds, and these studies are currently underway. were previously synthesized and their 1 H and 13 C NMR spectra have been reported.
EXPERIMENTAL

13
General Procedure for the Synthesis of Urea and Thiourea Analogs:
Step-A. In a 100 mL roundbottom flask, the centrally Boc substituted diamino compounds 43 (0.5 mol) were dissolved in 10 mL of HPLC grade CH 2 Cl 2 , and added a solution of alkyl-, benzyl-, or phenyl-substituted isocyanate or isothiocyanate, 44 (1.0 mmol, 2 equiv) in 5 mL of CH 2 Cl 2 under cold condition. The flask was protected with N 2 atmosphere and the reaction mixture was allowed to stir at room temperature for 18-
Step-B: The above crude product was dissolved in anhydrous MeCO 2 Et (6.0 mL), and added 1M HCl in MeCO 2 Et (6.0 mL), the reaction mixture becomes cloudy. The flask was protected with N 2 atmosphere and the reaction mixture was allowed to stir at room temperature for 24-48 h, the progress for formation of product was monitored by TLC using CH 2 Cl 2 :MeOH:NH 4 OH (89:10:1 and 78:20:2).
After completion of the reaction as confirmed by TLC, and the nature of the product (white crystalline materials separated from the solution), MeCO 2 Et was removed under reduced pressure on a rotary evaporator to produce a white powder. The solid product was well stirred with 20 mL of fresh MeCO 2 Et, and decanted the soluble part, the solid so obtained was vacuum dried to give pure product as a white solid. 
1,14-Bis-{3-[1-(ethyl)thioureado]}-4,11-diazatetradecane Hydrochloride 32 (RJB-92-08):
General Procedure for the Synthesis of Amidine Analogs:
The diamino compound 43 (0.50 mmol) was dissolved in 12 mL of absolute ethanol, and added a solution of S-2-Naphthylmethyl Thioacetimidate Hydrobromide 46 (310 mg, 1.0 mmol, 2 equv.) under cold condition. The flask was protected with N 2 atmosphere and the resulting suspension that eventually becomes homogenous was allowed to stir at room temperature for 48-72 h, the progress for formation of product was monitored by TLC using CH 2 Cl 2 /MeOH/NH 4 OH (89:10:1). After completion of the reaction, the ethanol was removed under reduced pressure on a rotary evaporator to produce a viscous colorless material which was purified by stirring the mixture with dry ether, discarded ether soluble part, and insoluble material was again stirred with fresh ether (25 mL). The white solid so obtained was dried in vacuum. 
1,11-Bis-(acetamidinyl)-4,8-di(tert-butyloxycarbonyl)-4,8-diazoundecane Hydrobromide
MeCO 2 Et for 5 min, and added 1M HCl in MeCO 2 Et (5 mL). The flask was protected with N 2 atmosphere and the reaction mixture was allowed to stir at room temperature for 24-48 h,
In vitro assessment of antimalarial activity
In vitro activity against erythrocytic stages of P. falciparum (strains 3D7 and W2) was determined using the Malaria SYBR Green I-based fluorescence assay (MSF) 25 based on the DNA binding properties of this dye. Compounds were dissolved in a non-lethal DMSO concentration (< 0.013%), 26 serially diluted and added to ring stage P. falciparum (1% parasitemia, 2% hematocrit) and incubated at 37˚C, static for 96 h. Subsequently, equal volumes (100 µl) of the parasite suspension were added to SYBR Green I lysis buffer [0.2 µL/mL of 10 000x SYBR Green I (Invitrogen), 20 mM Tris, pH 7.5; 5 mM EDTA; 0.008% (w/v) saponin; 0.08% (v/v) Triton X-100] and incubated in the dark for 1 hr at room temperature. Fluorescence was read with a Fluoroskan Ascent FL microplate reader at an excitation of 485 nm and emission of 538 nm. The data was represented as percentage of untreated control to determine cell proliferation. Non-linear regression curves were generated using Sigma Plot 11.0, from which the 50% inhibitory concentrations (IC 50 ) could be determined. Each compound was tested in duplicate for at least three independent biological replicates.
Determination of parasite DNA replication
The effect of the compounds on P. falciparum DNA replication and nuclear division was determined using flow cytometry. Parasites (2% parasitemia, 2% hematocrit) were treated with test compounds 
Determination of polyamine reversal of inhibition
The ability of exogenous putrescine to rescue polyamine analogue treated parasites was determined using polyamine reversal studies that were set up in the format similar to that of the MSF assay. P.
falciparum 3D7 cultures were treated in early ring stages with test compounds at 2xIC 50 . After 24 and after which parasitemia was determined as described for the MSF assay. Statistical analysis was performed with GraphPad InStat 3.10, all data given are the mean of at least three independent biological repeats.
Cytotoxicity determinations in mammalian cells
Human hepatocellular liver carcinoma cells (HepG2, kind gift by Duncan Cromarty, University of Pretoria) were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10%
heat inactivated fetal bovine serum and 1% penicillin/Streptomycin at 37°C (5% CO 2 , 90% humidity).
Cytotoxicity was measured using the lactate dehydrogenase assay (LDH). Cells (100 000) were seeded in 96-well plates and grown for 24 h at 37°C, after which cells were treated with various concentrations of the compounds. After 48 h exposure, cells were pelleted at 250xg for 10 min and LDH activity was 
